BioCryst Pharmaceuticals
BCRX
#4944
Rank
C$2.71 B
Marketcap
C$10.56
Share price
-0.87%
Change (1 day)
7.12%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2026 (TTM): -C$0.5 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are C$0.96 Billion. In 2025 the company made an earning of C$0.38 Billion, an increase over its 2024 earnings that were of -C$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.5 Billion-229.42%
2025 C$0.38 B-407.51%
2024 -C$0.13 Billion-61.56%
2023 -C$0.33 Billion-7.43%
2022 -C$0.35 Billion34.42%
2021 -C$0.26 Billion-0.55%
2020 -C$0.27 Billion67.88%
2019 -C$0.16 Billion7.55%
2018 -C$0.15 Billion53.92%
2017 -C$94.04 Million19.29%
2016 -C$78.83 Million28.19%
2015 -C$61.5 Million-4.8%
2014 -C$64.6 Million50.09%
2013 -C$43.04 Million-23.29%
2012 -C$56.11 Million-26.19%
2011 -C$76.02 Million54.78%
2010 -C$49.12 Million150.1%
2009 -C$19.64 Million-49.43%
2008 -C$38.83 Million14.07%
2007 -C$34.04 Million-49.31%
2006 -C$67.16 Million72.87%
2005 -C$38.85 Million22.08%
2004 -C$31.83 Million75.3%
2003 -C$18.16 Million-25.36%
2002 -C$24.33 Million225.05%
2001 -C$7.49 Million-56.6%
2000 -C$17.25 Million50.63%
1999 -C$11.45 Million38.05%
1998 -C$8.3 Million-52.46%
1997 -C$17.44 Million58.44%
1996 -C$11.01 Million-14.44%
1995 -C$12.87 Million28.57%
1994 -C$10.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
-C$3.63 Billion 614.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$10.22 B-2,116.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-C$0.19 Billion-63.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C$43.85 M-108.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-C$0.32 Billion-37.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.47 Billion-8.15%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-C$11.75 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-C$31.82 Million-93.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-C$0.28 Billion-45.14%๐Ÿ‡บ๐Ÿ‡ธ USA